Apogee Therapeutics Inc (APGE)
SG&A Expense Growth
44.64%
Fiscal year · Period ending:
APGE SG&A Expense Growth
Latest reported44.64%period ending
Latest reported44.64%period ending
APGE FY SG&A Growth (YoY) (0.00% → 44.64%)
Latest values, visible window
High-resolution chart · PNG
APGE sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 44.6444% | |
| 99.3775% | |
| 735.7361% | |
| 0% |